We have compared the phenotypes of the two common deletion forms of alpha+-thalassemia by analysis of umbilical cord blood samples from Melanesia. Homozygotes for the leftward, 4.2-kilobase, deletion (-alpha 4.2) had significantly higher levels of Hb Bart's at birth than homozygotes for the rightward, 3.7-kilobase, deletion (-alpha 3.7). Compound heterozygotes for each deletion had intermediate values. Although deletion forms of alpha 0 thalassemia were not found in this survey, nondeletion alpha-thalassemia was present at low frequency. Since the predominant rightward deletion in this population, -alpha 3.7III, entirely removes the alpha 1-gene and the 4.2-kilobase deletion deletes the alpha 2-gene, these data indicate that the alpha 2-globin gene has a higher output than the alpha 1-gene, on single alpha-gene chromosomes.
Introduction
The human a-globin gene complex on chromosome 16 (1) comprises two adult a-genes, a jVa-gene, and an embryonic A-and 4Vu-gene arranged in the order 5' -t2-4t'1 -&a -a2 -al -3' (2). Large deletions within this complex removing all or part of the genes are much more common causes of a-thalassemia than point mutations or minor rearrangements that produce the nondeletion forms of this condition (3, 4) . Eight deletions causing a-thalassemia have been described. Two of these, which remove a single a-gene and produce a'-thalassemia are by far the most prevalent (5), one deleting 4.2 kilobases (kb) of DNA (-a4 .2) and the other 3.7 kb (-a37) (6) . Indeed, the latter is possibly the most common mutation known to produce a genetic disorder. It is prevalent in most tropical and subtropical populations that have been studied including African and American Blacks (7), Mediterraneans (8) , Southeast Asians (9) , and some Pacific Island populations (10) . In contrast the 4.2-kb single gene deletion (-a42) is very rare in Blacks and Mediterraneans but is more common in Southeast Asia and the Middle East (3) . Remarkably, in north coastal Papua New Guinea the -a4_2 deletion is found in >80% of the population and appears to be going to fixation (1 1). These two types of a+-thalassemia are phenotypically less severe than the ao thalassemia determinants that completely abolish a-chain output from the affected chromosome. However, despite their prevalence, no detailed comparison of the phenotypes of-a3.7 and -a4_2 deletions has been performed. Such a study would be of clinical interest and, because -a4'2 deletions remove the a2-gene and -a37 deletions remove either the entire al-gene or produce a hybrid a2-al gene, might additionally provide some information on the relative expression -of the residual a2-or a 1 -globin genes on chromosomes carrying only a single a-gene (-a).
We have compared the phenotype of these conditions by aglobin gene mapping and quantitation of the level of Hb Bart's (4, 12, 13) (15) . DNA extraction and gene analysis by the Southern blot technique were as described previously (15) . All (Table II) showed that most samples without a gene deletion had no detectable Hb Bart's. However, 26 samples without deletions showed Hb Bart's at levels of 0.44-3.7%, which suggests the presence of nondeletion forms of a-thalassemia in this population. An approximate figure for the frequency of such chromosomes may be derived by assuming that these 26 individuals are heterozygotes for nondeletion a-thalassemia, leading to a gene frequency of (26/472) 0.055.
As has been found in surveys in Jamaica (12) and South Africa (19) there were several -a-heterozygotes in which no Hb Bart's was detectable. In 3 of the 15 cases this is probably due to the presence of a triplicated a-gene arrangement (20, 21) on the other chromosome (giving a total of four a-genes), which should compensate for the a-chain deficit due to the deletion. In the other 12 cases of genotype -a/aa, the a-chain deficiency is presumably insufficient to produce a detectable amount of Hb Bart's.
Comparison of the amount of Hb Bart's present in individuals with different genotypes (Fig. 1) showed two related findings. Number of individuals with each genotype identified in the cord blood survey. Two -a-haplotypes were not classified because of insufficient DNA. All aaa-chromosomes were of the aaaanu 3-7 type (20) . In five of the -a3 7/aa cases and one of the -a37/aaa cases, Hb JTgi (24) was found on hemoglobin electrophoresis. 45 of these -a3_7 deletions were subtyped; 38 were -a3 7III; and 7 were -a3-7I deletions. Fig. 2 were subtyped using the restriction enzymes Apa I and Rsa 1 (14) . 18 (-a'42) deletion predominates (3, 10) .
In Vanuatu, each is present at a significant frequency, allowing comparison of their phenotypes. Analysis of the red cell indices of adults heterozygous and homozygous for these deletions failed to show significant differences between the two types ofdeletion (Table III) (22) . However, measurement of levels of Hb Bart's at birth provides a more sensitive index of a-chain deficiency, and this is not known to be complicated by other factors that may affect red cell indices in the tropics. The higher levels at birth of Hb Bart's associated with the -a4 2 deletion indicates that this defect generates a greater a-chain deficit than the -a3-711I deletion. The data on Melanesians heterozygous for the -a 7 defect are in agreement with studies in Jamaica and South Africa (12, 19) , which found that this defect is not always associated with detectable amounts ofHb Bart's in cord blood. Interestingly, in Southeast Asia, where both the -a3 7 and -a42 deletions are found, Hb Bart's was more often detectable in _a4.2 heterozygotes (13).
Analysis of the percentage of variant hemoglobins in individuals with both an a-chain variant and one or two deletion chromosomes might provide some indication of the relative expression of the -a3.7 and _a4.2 chromosomes in adult life. Limited data on the Hb jTongaiki (24) and Hb Q (25) variants suggest that the -a4-2 deletion may produce a slightly more severe phenotype, but many further such examples would be required to confirm this. Comparison of the phenotypes of individuals with Hb H disease who have either the -a3.7 or -a42 deletion as well as an a'-chromosome, should provide further data on this question. However, from the red cell indices data (Table  III) it is clear that any difference between the phenotypes in adult life must be small.
Studies of the proportions of a-chain variants in heterozygotes and homozygotes first suggested that the human a-globin gene was duplicated, and indicated that the output of each of the two genes was similar (26, 27) . However, because ofpossible differences in affinities for ,B-chains, rates of synthesis, and stabilities of a-chain variants, it is difficult to extrapolate from the percentage of a variant to the level of expression of its gene. Furthermore, in the case ofmost a-variants on aa-chromosomes it is not known which gene carries the mutation (28) . Hence, small differences in the level of expression of the two a-genes would not have been apparent from these studies. DNA sequence analysis and restriction enzyme mapping have shown that whereas the -ac42 deletion leaves the a 1-gene intact, the -a3_711I deletion found in Vanuatu leaves a single intact a2-gene (14, 29) . Hence, the Hb Bart's data indicate that, on these single agene chromosomes, the a2-gene produces more a-globin than the al -gene. Although this is consistent with other observations which suggest that the a2-gene may also be more active on aachromosomes (30, 31) , it is not valid to make such a simple extrapolation. For example, it has recently been demonstrated that there is a compensatory increase in expression of the single a-gene in heterozygotes for the -a3-7 deletion (32) . This could in part explain the observation that these heterozygotes do not always have detectable levels of Hb Bart's at birth (Fig. 1) (12) , and further similar studies on -a4'2 heterozygotes will be of interest.
There are now several lines of evidence which suggest that the a2-gene may produce more globin than the atl-gene, on aaas well as -a-chromosomes. Firstly, two independent studies have shown that, in normal (aa/aa) individuals, the amount of a2-messenger RNA (mRNA) exceeds that of al by 1.5-2.8-fold, probably due to increased transcription ofthe a2-gene (30, 31) . al-mRNA has been shown to have a higher translational efficiency than a2-mRNA and it was suggested that this balances the increased transcription of the a2-gene, so that each gene produces an equal amount of a-globin (33). However, the precision of such studies, particularly given the range of estimated a2/a1 mRNA levels, is insufficient to exclude a slightly higher output from the a2-gene. Clearly, it would be of interest to perform similar analyses on these Melanesian individuals, though this would necessitate a more sophisticated method of sample collection than has so far been possible in these remote island populations. Secondly, it is remarkable that all ofthe nondeletion a-thalassemias which have been analyzed to date (reviewed in references 3 and 28) have been associated with a mutation in the a2-gene. (One also has an additional mutation in the al gene [3] ). Since there is no other evidence for increased mutation in the a2 compared with the al gene this may reflect a selection bias. If the a2-gene is normally more active, point mutations in this gene would produce a more severe phenotype than al-mutations and might be more likely to be selected and detected. Interestingly, these nondeletion mutations affecting the a2-gene produce a more severe phenotype than single a-gene deletions (3, 34) , presumably because of a compensatory increase in the expression of the residual al-gene in the -a4'2 deletion (32) .
Similarly, the a2-gene chain termination mutant, Hb Constant Spring, produces a relatively severe form of a'-thalassemia (35) .
Although none of these studies provide unequivocal evidence, taken together they are consistent in suggesting a higher output from the a2-gene.
Because the sequence of both the a2-and al-genes and the structure of each type of deletion chromosome have been defined (2, 6, 14, 29) , it is possible to identify the sequence differences between the -a37-III and -a4.2 chromosomes that are presumably responsible for the difference in expression between the two. These differences are 20-point mutations and a 7 basepair deletion at the 3' end of the a-gene, and more substantial differences 1 kb 5' to the gene in the region of the Y homology box (2, 29) . The relative importance of these two regions of sequence difference could be indicated by comparison of the phenotype of the -a-37I deletion, which has the same 3' region as the _a4.2 chromosome and the same 5' region as the -a-37III chromosome, with the -a37III and the _a4-2 phenotypes. The -a37I chromosomes identified in this study suggest that this deletion is more similar to the -a3 71II than the -a4-2 deletion, which indicates that the upstream sequence differences may be of more importance. Hence, although the -a3 71 deletion leaves a residual a-gene that is al-like in sequence, its phenotype may differ from that of the -a4-2 deletion because of the presence of upstream sequences in the -a3711I that are deleted on the _a4.2 chromosome. However, because of the small number of -a37I deletions detected in this study, further comparison of the -a37I and -ac42 phenotypes is required.
At present it is not possible to develop a unifying model to account for the phenotypes of the different -a-deletions in terms of the particular sequences that determine transcriptional and translational efficiencies. However, because of the very limited sequence differences between these duplicated genes, further analysis both in vitro and in vivo of the expression of each of the four types of -a-chromosome should further our understanding of gene expression and its control in man.
